Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of GSK's HZ/su herpes zoster vaccine in adults with prior herpes zoster infection; st…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020 [Phase 4]
Phase 4 clinical trial assessing T cell responses to the Varicella Zoster Virus vaccine SLVP020 in adults with herpes zoster; study complete…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062) [Phase 3]
A Phase 3 study evaluating immunogenicity, safety, and tolerability of ZOSTAVAX administered concomitantly with quadrivalent influenza vacci…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: ZOSTAVAX® in Renal Transplant Patients [Phase 1]
Phase 1 trial of ZOSTAVAX in renal transplant patients has completed, evaluating herpes zoster prevention.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years [Phase 3]
Phase 3 safety and immunogenicity study of GSK1437173A (HZ/su) vaccine for herpes zoster completed; results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-12-21FDA Approved: ACYCLOVIR — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical’s original generic application for acyclovir (oral). The approval enables the commercial production of a gen…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older [Phase 1, Phase 2]
Clinical trial update reporting safety and immunogenicity results of a live attenuated herpes zoster vaccine in Chinese adults aged 50 and o…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food [Phase 1]
Phase 1 study evaluating the safety, pharmacokinetics, and the effect of food on single doses of ASP2151 in healthy male subjects; the trial…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Herpes Zoster Prevalence in Frailty Consultations
The trial has completed and reports on the prevalence of herpes zoster in frailty consultations.
-
FDA approval · 2016-04-08FDA Approved: ACYCLOVIR — Supplemental Application (Quinn Pharmaceuticals)
FDA approved a supplemental application for acyclovir submitted by Quinn Pharmaceuticals, indicating regulatory approval of a supplement for…
-
FDA approval · 2016-03-25FDA Approved: ACYCLOVIR — Original Application (Viona Pharmaceuticals Inc)
FDA approves the original application for acyclovir from Viona Pharmaceuticals Inc, making a generic version of acyclovir available.
-
FDA approval · 2016-03-24FDA Approved: FAMCICLOVIR — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for famciclovir from Aurobindo Pharma Limited (ANDA 091114), indicating approval of a supplemental s…
-
FDA approval · 2016-03-04FDA Approved: FAMCICLOVIR — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to market a generic version of famciclovir.
-
FDA approval · 2016-02-29FDA Approved: ACYCLOVIR — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc. for an original application of acyclovir as a generic product, expanding generic options for acy…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older [Phase 3]
This Phase 3 trial update reports immunogenicity and safety results for GlaxoSmithKline's recombinant zoster vaccine (Shingrix) when co-admi…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared With Placebo in Subjects With Acute Herpes Zoster (Shingles) Pain [Phase 1]
A Phase 1 trial evaluating the safety and pharmacokinetics of a 40% lidocaine topical gel versus placebo for acute herpes zoster pain, spons…
-
FDA approval · 2015-10-26FDA Approved: VALACYCLOVIR — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Valacyclovir submitted by Quallent Pharmaceuticals Health LLC. The action confirms regulator…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster [Phase 2]
This Phase 2 trial compares FV-100 versus valacyclovir for treatment of herpes zoster (shingles). The study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers [Phase 1]
This Phase 1 pharmacokinetic study assesses FV-100 with and without ritonavir in healthy volunteers to evaluate potential drug-drug interact…
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain
A completed GlaxoSmithKline-sponsored clinical trial in Spain aimed at estimating the burden of herpes zoster and postherpetic neuralgia.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in Thailand
A completed clinical study conducted in Thailand to measure the burden of herpes zoster and postherpetic neuralgia, along with related healt…
-
FDA approval · 2015-08-20FDA Approved: ACYCLOVIR — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for acyclovir from Amneal Pharmaceuticals LLC, supporting a generic formulation of acyclovir.
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014) [Phase 3]
A Phase 3 lot-to-lot consistency study of an inactivated Varicella Zoster Virus vaccine in healthy adults has been withdrawn.
-
FDA approval · 2015-04-08FDA Approved: VALACYCLOVIR — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved Quallent Pharmaceuticals Health LLC's original ANDA for Valacyclovir, providing a generic option for treating common herpes inf…
-
FDA approval · 2014-10-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Valacyclovir hydrochloride from Aurobindo Pharma Limited, granting approval of a generic product…